These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4201656)

  • 1. The effect of clinical pharmacy services on patients with essential hypertension.
    McKenney JM; Slining JM; Henderson HR; Devins D; Barr M
    Circulation; 1973 Nov; 48(5):1104-11. PubMed ID: 4201656
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantifying the opportunity for pharmacists to improve management of hypertension in a primary care medical clinic.
    Padiyara RS; D'Souza JJ
    J Manag Care Pharm; 2008 Apr; 14(3):322-3. PubMed ID: 18439057
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical care for hypertensive patients.
    Carter BL
    Am Pharm; 1994 Jan; NS34(1):54-61; quiz 61-3. PubMed ID: 8166038
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of a hypertension care management program provided by clinical pharmacists for veterans.
    Bex SD; Boldt AS; Needham SB; Bolf SM; Walston CM; Ramsey DC; Schmelz AN; Zillich AJ
    Pharmacotherapy; 2011 Jan; 31(1):31-8. PubMed ID: 21182356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant hypertension in the elderly: optimizing outcomes while avoiding adverse effects.
    Strunk AD; Mayer SD
    Consult Pharm; 2013 May; 28(5):307-12. PubMed ID: 23649679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
    Winslade N; Tamblyn R
    BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical care services for patients with hypertension.
    Carter BL; Zillich AJ
    Ann Pharmacother; 2003 Sep; 37(9):1335-7. PubMed ID: 12921520
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient acceptability of and readiness-to-pay for pharmacy-based health membership plans to improve hypertension outcomes in Lima, Peru.
    Vodicka E; Antiporta DA; Yshii Y; Zunt JR; Garcia PJ
    Res Social Adm Pharm; 2017; 13(3):589-601. PubMed ID: 27344393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical care and health outcomes in community settings: a matched pair analysis of perceptions of hypertensive patients versus pharmacists.
    Franic D; Pathak DS; Mott D
    Pharm Pract Manag Q; 1999 Jul; 19(2):1-17. PubMed ID: 10558091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system.
    Kroner BA; Billups SJ; Garrison KM; Lyman AE; Delate T
    J Manag Care Pharm; 2008 Mar; 14(2):155-63. PubMed ID: 18331117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of a patient-based pharmaceutical care scale.
    Sen SS; Thomas J
    Am J Health Syst Pharm; 2000 Sep; 57(17):1592-8. PubMed ID: 10984810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of partial patients' adherence to antihypertensive drugs: scope for pharmacists' role in hypertension care.
    Sitbon M; Corny J; Beaussier H; Bézie Y
    Int J Clin Pharm; 2018 Feb; 40(1):1-2. PubMed ID: 29116462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community Pharmacy and Blood Pressure Control.
    Shireman TI
    Circulation; 2015 Jul; 132(2):75-6. PubMed ID: 26063763
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback.
    Winslade N; Eguale T; Tamblyn R
    BMJ Open; 2016 May; 6(5):e010865. PubMed ID: 27207626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension: a model for pharmacy involvement.
    Mattei TJ; Balmer JA; Corbin LA; Gonzales Duffy M
    Am J Hosp Pharm; 1973 Aug; 30(8):683-6. PubMed ID: 4722845
    [No Abstract]   [Full Text] [Related]  

  • 20. Home blood pressure monitoring: a new standard method for monitoring hypertension control in treated patients.
    Pickering TG
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):762-3. PubMed ID: 18852711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.